They also maintain liaison relationships with medical and nursing staff, provide timely information pertaining to pharmaceutical supplies, drug usage and compatibility, state and federal regulations regarding drug controls.
Hematology / oncology faculty member (any rank) with clinical / translational research interests in hematological malignancies to join a robust cutting-edge leukemia section in the department of medicine.
Recruiting faculty members with an interest in thoracic and head and neck medical oncology to fill positons at assistant, associate or professor levels. Assistant professor candidates will be expected to demonstrate interest and capability in the management and clinical care of patients with thoracic/head and neck cancers.
He candidate must have a commitment to excellence in patient care, research and education. All faculty members are involved in clinical research, teaching students, residents and fellows. Experience in robotic surgery is required.
The team is well established and collegial and supported by 5 dedicated nps/pas and a team of dedicated gI research coordinators and clinical care coordinators. Additionally, you will have access to a solid infrastructure to conduct trials, write grants and collaborate with immunotherapy core scientists in developing novel targeted therapies.
The hematopathology clinical service is divided among bone marrow transplant, myeloid, lymphoid, and plasma cell disorders. State of the art ancillary services include flow cytometry, molecular diagnostics, and conventional cytogenetics support the clinical mission.
The successful candidate will join a cytopathology staff of three fellowship trained and board certified cytopathologists, five ascp certified cytotechnologists and three technicians with an overall clinical volume of more than 8000 cytopathology cases.
The successful candidate will have the opportunity to participate in rpci's multidisciplinary approach to research and teach residents and fellows. The department supports a free standing cancer institute providing both inpatient and outpatient care. Institutional strengths include leukemia and lymphoma/myeloma services, with the bone marrow transplant service.
The center for immunotherapy is looking for a postdoctoral candidate to work on research efforts focusing on the development of innovative immunotherapies for cancer based on genetically engineered lymphocytes and cellular components of the tumor microenvironment.
This will include the development of pipelines for wgs data using existing tools, annotation and functional analysis from wgs data and possible integration of epigenetic, expression and other high-throughput data, and the development of new analytic methods for wgs and integration studies.
Postdoctoral fellowship in tumor biology is available immediately to study the molecular mechanisms and therapeutic interventions associated with focal adhesion kinase (fak) modulation of the near-universal phenomenon of aerobic glycolysis and abnormal survival.
Candidates are sought with a strong background in translational cancer research with special interests in, but not limited to, tumor immunotherapy and combinatorial therapies involving chemo-, radio-, and/or immunotherapy.